Literature DB >> 453354

A systematic investigation of tardive dyskinesia in inpatients.

J M Smith, L T Kucharski, W T Oswald, L J Waterman.   

Abstract

Although many scales to measure tardive dyskinesia have been developed, none has been widely accepted. The authors used the Abnormal Involuntary Movement Scale (AIMS) to evaluate a group of 293 inpatients who had been given a primary or secondary diagnosis of schizophrenia. They found a tardive dyskinesia prevalence of 30% using a criterion rating of 3 (moderate symptoms) or more on the AIMS. The prevalence figure declined as the criterion became more severe. They also found that women had a much higher prevalence of the disorder only when more severe symptoms were used as the criterion. They conclude that the AIMS is a reliable instrument for assessing tardive dyskinesia.

Entities:  

Mesh:

Year:  1979        PMID: 453354     DOI: 10.1176/ajp.136.7.918

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  10 in total

1.  Diurnal and weekly variation of tardive dyskinesia measured by digital image processing.

Authors:  J K Stanilla; C Büchel; J Alarcon; J de Leon; G M Simpson
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

2.  Topographic subtypes of tardive dyskinesia in schizophrenic patients aged less than 60 years: relationship to demographic, clinical, treatment, and neuropsychological variables.

Authors:  O Gureje
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

Review 3.  Tardive dyskinesia in non-western countries: a review.

Authors:  A K Pandurangi; Y A Aderibigbe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

4.  An assessment of tardive dyskinesia in schizophrenic outpatients.

Authors:  J M Smith; L T Kucharski; C Eblen; E Knutsen; C Linn
Journal:  Psychopharmacology (Berl)       Date:  1979-06-28       Impact factor: 4.530

5.  Initiating clozapine treatment service and characteristics of clozapine-treated patients in a general hospital in Addis Ababa, Ethiopia.

Authors:  Solomon Teferra
Journal:  S Afr J Psychiatr       Date:  2020-06-24       Impact factor: 1.550

6.  Absence of severe tardive dyskinesia in Hungarian schizophrenic out-patients.

Authors:  G Gardos; I Samu; M Kallos; J O Cole
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

7.  The treatment of tardive dyskinesia with baclofen.

Authors:  W M Glazer; D C Moore; M B Bowers; B S Bunney; M Roffman
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  Prevalence of spontaneous dyskinesia in first episode, drug naive schizophrenia, and its relation to the positive and negative symptoms of schizophrenia.

Authors:  Samrat Singh Bhandari; Dipesh Bhagabati
Journal:  Open J Psychiatry Allied Sci       Date:  2016-12-30

9.  Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder.

Authors:  Oliver D Howes; Michael J Wheeler; Lyn S Pilowsky; Sabine Landau; Robin M Murray; Shubulade Smith
Journal:  J Clin Psychiatry       Date:  2007-03       Impact factor: 4.384

10.  Schizophrenia Spectrum Disorders Show Reduced Specificity and Less Positive Events in Mental Time Travel.

Authors:  Xing-Jie Chen; Lu-Lu Liu; Ji-Fang Cui; Ya Wang; An-Tao Chen; Feng-Hua Li; Wei-Hong Wang; Han-Feng Zheng; Ming-Yuan Gan; Chun-Qiu Li; David H K Shum; Raymond C K Chan
Journal:  Front Psychol       Date:  2016-07-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.